Expanding Treatment Options for Improving Health Outcomes in Type 1 Diabetes
Garg SK
Diabetes Technology & Therapeutics. Pub. online September 2017
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Adult-Onset Autoimmune Diabetes: Current Knowledge and Implications for Management
Buzzetti R, Zampetti S and Maddaloni E
Nature Reviews Endocrinology. Pub. online 08 September 2017
Leggi
FDA Approval of Nonadjunctive Use of Continuous Glucose Monitors for Insulin Dosing. A Potentially Risky Decision
Shapiro AR
JAMA. Pub. online September 14, 2017
Leggi
Continuous Glucose Monitoring in Pregnant Women With Type 1 Diabetes
Garg SK, Polsky S
The Lancet. Pub.online15 September 2017
Leggi
Risk of Atrial Fibrillation in People With Type 1 Diabetes Compared With Matched Controls From The General Population: A Prospective Case-Control Study
Dahlqvist S, Rosengren A, and Gudbjörnsdottir S
The Lancet Diabetes & Endocrinology. 2017;5(10):799-807
Leggi
Is Atrial Fibrillation Another Manifestation of Organ Damage in Diabetes?
Miyazawa K and Lip GYH
The Lancet Diabetes & Endocrinology. 2017;5(10):761-2
Leggi
Effects on the Incidence of Cardiovascular Events of the Addition of Pioglitazone Versus Sulfonylureas in Patients with Type 2 Diabetes Inadequately Controlled with Metformin (TOSCA.IT): A Randomised, Multicentre Trial
Vaccaro O, Masulli M, Nicolucci A, et al. for Thiazolidinediones Or Sulfonylureas Cardiovascular Accidents Intervention Trial (TOSCA.IT) study group
Lancet Diabetes Endocrinol. Pub. online 13 September 2017
Leggi
Pioglitazone Versus Sulfonylureas: Cardiovascular Outcomes with Older Diabetes Drugs
Fonseca VA, Lovre D
Lancet Diabetes Endocrinol. Pub. online 13 September 2017
Leggi
Effects of Acarbose on Cardiovascular and Diabetes Outcomes in Patients with Coronary Heart Disease and Impaired Glucose Tolerance (ACE): A Randomised, Double-Blind, Placebo-Controlled Trial
Holman RR, Coleman RL, Chan JCN, et al.
Lancet Diabetes Endocrinol. Pub. online 13 September 2017
Leggi
Break Point Instead of ACE: Acarbose, Post-Load Glycaemic Excursions, and Cardiovascular Events
Nauck MA, Meier JJ
Lancet Diabetes Endocrinol. Pub. online 13 September 2017
Leggi